SCHEMBL22925582

SCHEMBL22925582

Cc1ccc(-c2cnc(Nc3cnc(C(=O)N(C)O)c(C)c3)o2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.53
▸ KDR P35968 9/20 0.45
▸ FLT1 P17948 8/20 0.45
▸ FLT4 P35916 7/20 0.45
▸ IMPDH2 P12268 2/20 0.42
▸ VCP P55072 4/20 0.41
▸ DGAT1 O75907 1/20 0.38
▸ TRPV1 Q8NER1 1/20 0.38
▸ PRKAB2 O43741 1/20 0.38
▸ LCK P06239 1/20 0.38
▸ SRC P12931 1/20 0.38
▸ FLT3 P36888 1/20 0.38
▸ PRKAG1 P54619 1/20 0.38
▸ PRKAA2 P54646 1/20 0.38
▸ PRKAA1 Q13131 1/20 0.38
▸ RPS6KA1 Q15418 1/20 0.38
▸ MKNK1 Q9BUB5 1/20 0.38
▸ PRKAG3 Q9UGI9 1/20 0.38
▸ PRKAG2 Q9UGJ0 1/20 0.38
▸ PRKAB1 Q9Y478 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22925990 0.89 ALOX5 (0.51) ALOX5KDRFLT1FLT4VCP
SCHEMBL22925574 0.86 ALOX5 (0.57) ALOX5KDRFLT1FLT4IMPDH2
SCHEMBL22925668 0.79 TRPV1 (0.46) ALOX5KDRFLT1FLT4VCP
SCHEMBL28733809 0.78 VCP (0.56) ALOX5KDRFLT1FLT4VCP
SCHEMBL24637048 0.75 ALOX5 (0.55) ALOX5KDRFLT1FLT4VCP
SCHEMBL22925577 0.74 ALOX5 (0.53) ALOX5KDRFLT1FLT4DGAT1
SCHEMBL24636900 0.70 KDR (0.51) ALOX5KDRFLT1FLT4IMPDH2
SCHEMBL29696307 0.70 TRPV1 (0.46) ALOX5KDRFLT1FLT4VCP
SCHEMBL22925770 0.70 TRPV1 (0.46) ALOX5KDRFLT1FLT4VCP
SCHEMBL14134239 0.69 KDR (0.66) ALOX5KDRFLT1FLT4IMPDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021012018-A1 INHIBITOR COMPOUNDS Cincera Therapeutics Pty Ltd (AU) 2021-01-28 — — WO disclosed
Send feedback